Precision Dosing: History and Current Status
Precision dosing is an approach to use various patient-specific data sources to individualize pharmacotherapy of critical medicines used in the care of disease and other conditions for which drug therapy is recommended. Often the “data” in question refers to therapeutic drug monitoring of drug concentrations in blood or plasma. More recently, biomarkers and clinical outcomes have been used to further guide dose individualization for critical pharmacotherapy. The first model-informed precision dosing (MIPD) tool using both pharmacokinetics (PK) and pharmacodynamics (PD) data was developed in 1969, to assess optimal dosing for patients on anticoagulation therapy.

